ArticleCancer biology & therapy2015

The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.

Yafang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.